Atormac
Neurology India
Open access journal indexed with Index Medicus
  Users online: 1047  
 Home | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (1,793 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References
   Article Figures

 Article Access Statistics
    Viewed739    
    Printed3    
    Emailed0    
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
LETTERS TO EDITOR
Year : 2018  |  Volume : 66  |  Issue : 3  |  Page : 850-852

Peripheral primitive neuroectodermal tumor of cauda equina: A report and review of literature


1 Department of Neurosurgery, Muthoot Healthcare Ltd., Kozhencherry, Pathanamthitta, Kerala, India
2 Department of Pathology, Metropolis Healthcare Ltd., Mumbai, Maharashtra, India

Date of Web Publication15-May-2018

Correspondence Address:
Dr. A Ajaya Kumar
Consultant Neurosurgeon, Department of Neurosurgery, Muthoot Healthcare Ltd., Kozhencherry, Pathanamthitta, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.232344

Rights and Permissions



How to cite this article:
Kumar A A, Barodawala S. Peripheral primitive neuroectodermal tumor of cauda equina: A report and review of literature. Neurol India 2018;66:850-2

How to cite this URL:
Kumar A A, Barodawala S. Peripheral primitive neuroectodermal tumor of cauda equina: A report and review of literature. Neurol India [serial online] 2018 [cited 2018 Aug 20];66:850-2. Available from: http://www.neurologyindia.com/text.asp?2018/66/3/850/232344




Sir,

Peripheral primitive neuroectodermal tumor (PNET) has been reported, although rarely, as a cauda equina tumor. It is more aggressive than the common tumors of cauda equina viz. ependymoma and schwannoma. This is a report of a 65-year old man who had a PNET of the cauda equina.

The patient presented with low backache and pain radiating to both lower limbs. There was severe pain on walking, which was progressive. At the time of presentation, he could not walk at all and was bedridden. The straight leg raising test was positive at 60° on the left side. Magnetic resonance imaging (MRI) of the lumbosacral spine showed a well-defined oval-shaped lesion in the intradural space at the L2 vertebral level measuring 15 mm × 12 mm × 10 mm [Figure 1]a. The lesion exhibited intermediate signal on T1-weighted and T2-weighted sequences with intense homogeneous enhancement on contrast study [Figure 1]b. It also caused displacement and compression of the nerve roots and occupied the spinal canal completely.
Figure 1: (a) T2W sagittal image showing a well-defined oval-shaped lesion in the intradural space at the L2 vertebral level; (b) T1W contrast sagittal study showing an intense homogenous enhancement

Click here to view


An L2 laminectomy was done under general anesthesia in prone position. The bulging dura matter was opened. A yellow pink nodular tumor was seen amidst the nerve roots of the cauda equina [Figure 2]a and [Figure 2]b. The tumor was seen to be attached to two roots on either side and was dissected from the roots. The tumor was excised en toto. Bleeding was controlled using surgicel, and the dura was closed. Postoperative MRI showed complete excision of the tumor [Figure 2]c. He was ambulated and was relieved of his pain. Motor and sensory examination did not reveal any deficits.
Figure 2: (a) Tumor amidst roots of the cauda equina; (b) Yellow pink nodular tumor dissected from roots of the cauda equina; (c) Postoperative MRI showing complete removal of the tumor

Click here to view


Histopathological examination showed an encapsulated nodule composed of a malignant neoplasm showing a diffuse infiltrate of round cells with large nuclei, coarse chromatin, prominent nucleoli, and scanty cytoplasm [Figure 3]a. Atypical mitoses and focal areas of necrosis were noted. Immunohistochemistry was done. CD 99 (cluster of differentiation 99) had a strong and membranous positivity [Figure 3]b. Neuron-specific enolase and periodic acid Schiff tests were positive [Figure 3]c and [Figure 3]d. Vimentin was weakly positive. There was strong nuclear positivity for FLI (friend leukemia insertion)-1 [Figure 4]. The Ki-67 index was 20%. LCA (leukocyte common antigen), CD20 (cluster of differentiation 20), EMA (epithelial membrane antigen), Synaptophysin, GFAP (glial fibrillary acidic protein), Pan CK (pan-cytokeratin), CD138 (cluster of differentiation 138), Mum1(multiple myeloma oncogene 1), MPO (myeloperoxidase), and S100 were negative. A diagnosis of PNET was given. MRI screening of the whole body was done which was normal. Repeat MRI after 2 months did not show any recurrence. He is on follow-up for the last 8 months.
Figure 3: (a) Hematoxylin and eosin slide showing the round cell tumor; (b) the tumor is CD99 positive, (c) NSE positive; and (d) PAS positive

Click here to view
Figure 4: FLI-1 staining shows a strong nuclear positivity

Click here to view


The most common tumor of cauda equina is myxopapillary ependymoma.[1] The differentials reported are nerve sheath tumor, meningioma, paraganglioma, intradural metastases, lymphoma, other varieties of ependymoma, subependymoma, astrocytoma, ganglioglioma, hemangioblastoma, and PNET.PNET is rare in the cauda equina. It is common in the young and rare in the elderly patients.[2] For spinal PNET, the common sites are the filum terminale and cauda equina.

The term PNET was coined by Hart and Earle in 1973 to describe a predominantly undifferentiated tumor of the cerebrum.[3] PNET is a small round cell tumor of neural crest origin, typically seen in the second or third decades of life.[4] It is a highly malignant tumor, sharing morphological, histochemical, and immunogenetic features with Ewing's sarcoma. Primary spinal PNET is diagnosed when one or more histopathologically proven PNET lesions are present in the spinal axis, in the absence of a lesion in the brain. Secondary spinal PNET occurs due to subarachnoid seeding from a primary cranial PNET.[1] These are aggressive lesions characterized by a rapid growth, a short duration of symptoms, and tumor recurrence in most patients.

PNET histologically appears as a predominantly undifferentiated small, blue, round cell tumor with hyperchromatic nuclei, scanty cytoplasm, and frequent mitotic figures.[1] PNETs are classified into the central type and the peripheral type based on their origin. Central PNET has a central nervous system (CNS) origin and peripheral PNET has its origin outside the CNS. Peripheral PNET (pPNET) strongly expresses glycoprotein CD99. PNETs can be differentiated from other small round cell tumors viz. lymphoma, Ewing's sarcoma (ES), rhabdomyosarcoma, and small cell carcinoma by neural differentiation.[4],[5] ES/pPNETs are characterized by translocations that occur in 95% of the tumors. This translocation joins the Ewing's sarcoma gene (EWS) located on chromosome 22 to an ets family gene; either the friend leukemia insertion (FLI) 1 located on chromosome 11, t(11; 22) in 85% of cases, or the ets-related gene (ERG) located on chromosome 21, t(21; 22) in 10% of cases.[3] Immunohistochemical detection of FLI-1 may be valuable in confirming the diagnosis of ES/PNET in cases in which molecular genetic evaluation is not feasible.[6]

The present treatment of spinal PNET consists of local control in the form of surgery or radiotherapy combined with systemic control with chemotherapy.[4]

There are only few reports of PNET of the cauda equina. Mc Dermott et al., reported the case of a 47-year old man who had an unresectable cauda equina PNET for whom biopsy and radiotherapy were done; however, the patient died 1 year and 2 months later.[7] Akyuz et al., reported the case of a 31-year old female patient with a PNET of the cauda equina showing intracranial seeding 6 months after surgery.[8] Dhatt et al., reported the case of a 24-year old male patient with an L5 vertebral PNET with cauda equina syndrome.[4] Fabre et al., reported the case of a 70-year old man with a cauda equina PNET.[2] Isotalo et al., described pathological features of PNET of the cauda equina occurring in a 52-year old man.[5] Jitendra et al., reported a cauda equina tumor in a 11-year old boy, which turned out to be a PNET.[9] Near total removal, radiation, and chemotherapy were done. Kumar et al., reported an intracranial metastasis manifesting as a parietal tumor in a 22-year old female patient who had a cervicothoracic spinal PNET.[3] Metastasis occurring 10 years after the initial diagnosis in a spinal PNET has been reported by Gollard et al.[10] Spinal PNET that had an initial chronic inflammatory demyelinating polyneuropathy-like presentation in a young boy was reported by Chan et al.[11] Intramedullary PNET presenting with rapidly-progressive cauda equina syndrome in a 39-year-old male patient who underwent subtotal resection was reported by Tsutsumi et al.[12]

Most cases in the literature are of aggressive nature among young and middle-aged individuals. The uniqueness of our case is that the patient was 65-year old and complete excision was achieved. Another peculiarity is that the novel immunohistochemical marker FLI-1 was positive.

PNET should also be thought of in the differential diagnosis of a cauda equina tumor. It is a malignant tumor with a high chance of recurrence. Complete excision should be done if possible. Local control and systemic chemotherapy are needed.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Thoriya PJ, Watal P, Bahri NU, Rathod K. Primary primitive neuroectodermal tumour on MR imaging. Indian J Radiol Imaging 2015;25:459-63.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Fabre E, Guillevin R, Chretien F, Guerinel CL, Duffau H. Peripheral primitive neuroectodermal tumour of the cauda equina in an elderly patient, case report.J Neurosurg Spine 2006;5:68-71.  Back to cited text no. 2
    
3.
Ghanta RK, Koti K, Ghanta VSK, Teegala R. Intracranial metastasis from primary spinal primitive neuroectodermal tumour. Asian J Neurosurg 2013;8:42-6.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Dhatt S, Dillon MS, Tripathy SK, Goyal T, Jagadeesh V. Peripheral primitive neuroectodermal tumour causing cauda equina syndrome with destruction of L5 vertebra. Indian J Orthopaedics 2010:44:339-41.  Back to cited text no. 4
    
5.
Isotalo PA, Agbi C, Davidson B, Girard A, Verma S, Robertson SJ. Primary primitive neuroectodermal tumour of the cauda equina. Human Pathol 2000;31:999-1001.  Back to cited text no. 5
    
6.
Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: A study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000;24:1657-62.  Back to cited text no. 6
    
7.
Mc Dermott VGM, El-Jabbour JN, Sellar RJ, Bell J. Primitive neuroectodermal tumour of cauda equina. Neuroradiology 1994;36:228-30.  Back to cited text no. 7
    
8.
Akyuz M, Demiral AN, Gurer IE, Ucar T, Tuncer R. Primary primitive neuro-ectodermal tumour of cauda equine with intracranial seeding. Acta Neurochir 2004;146:525-8.  Back to cited text no. 8
    
9.
Sahu JK, Seth R, Karak AK, Thavaraj V, Kabra SK. Primitive neuroectodermal tumour presenting as cauda equina syndrome. Indian J Med Paediatr Oncol 2007;28:34-7.  Back to cited text no. 9
  [Full text]  
10.
Gollard RP, Rosen L, Anson J, Mason J, Khoury J. Intramedullary PNET of the spine-long term survival after combined modality therapy and subsequent relapse. J Paediatr Hemato Oncol 2011;33:107-12.  Back to cited text no. 10
    
11.
Chan SHS, Tsang DSF, Wong VCN, Chan GCF. Spinal primitive neuroectodermal tumour mimicking as chronic inflammatory demyelination polyneuropathy: A case report and review of literature. J Child Neurol 2015;30:254-8.  Back to cited text no. 11
    
12.
Tsutsumi S, Nonaka Y, Abe Y, Yasumoto Y, Nakazato Y, Ito M. Intramedullary primitive neuroectodermal tumour presenting with rapidly-progressive cauda equina syndrome. Neurol Med Chir (Tokyo) 2010;50:1031-5.  Back to cited text no. 12
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow